{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:37:32Z","timestamp":1786628252084,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Human schistosomiasis is a parasitic disease of major public health importance in sub-Saharan Africa. Mass drug administration (MDA) with praziquantel (PZQ) is the cornerstone of schistosomiasis control. However, its effectiveness is challenged by variable cure rates and rapid reinfection. Longitudinal data on reinfection and true incidence, which are critical for refining control strategies, are scarce from high-transmission foci like the Lango sub-region in Northern Uganda. This study assessed the efficacy of PZQ and the 24-week dynamics of reinfection and incidence of\n                      <jats:italic>Schistosoma mansoni<\/jats:italic>\n                      among school-aged children in this endemic area.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A 24-week prospective cohort study was conducted among 802 primary school children (aged 5\u201316 years). At baseline, participants were screened for\n                      <jats:italic>S. mansoni<\/jats:italic>\n                      using the modified Kato-Katz technique and allocated into an infected cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009279) and an uninfected cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009523). The infected cohort received a single 40\u00a0mg\/kg PZQ dose, with efficacy (cure rate-CR, egg reduction rate-ERR) assessed at 4 weeks. Treatment failures received a second dose. To measure true incidence, the uninfected cohort was re-screened at 4 weeks to identify and exclude prepatent infections at baseline. Reinfection in cured children and incidence in consistently negative children were assessed at 24 weeks.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The baseline prevalence was 34.8% (95% CI: 31.5\u201338.3). After the first PZQ dose, the cure rate was 82.1% (95% CI: 77.0-86.4), and the egg reduction rate was 32.9%. A second dose administered to non-responders achieved a 93.9% cure rate (95% CI: 83.6\u201397.9). At 24 weeks, the reinfection rate among cured children was 7.7% (95% CI: 4.9\u201311.8). After excluding prepatent infections (5.9%, 95% CI: 4.1\u20138.3) detected at 4 weeks, the true incidence of new infections was 5.0% (95% CI: 3.3\u20137.4) over the 24-week period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Praziquantel remains highly effective for treating\n                      <jats:italic>S. mansoni<\/jats:italic>\n                      in northern Uganda, and a second dose is valuable for curing initial treatment failures. However, the considerable burden of infection at baseline, coupled with notable reinfection and incidence rates within six months, signals persistent high transmission. Operationally, annual MDA may be insufficient; we advocate for piloting more frequent treatment (e.g., biannual MDA), integrating test-and-re-treat strategies (with careful cost-effectiveness evaluation), and strengthening complementary WASH and snail control interventions.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13757-x","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T10:03:13Z","timestamp":1780740193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Praziquantel efficacy and post-treatment reinfection and incidence of Schistosoma mansoni among school-aged children in Northern Uganda: a 24-week cohort study in a high transmission focus"],"prefix":"10.1186","volume":"26","author":[{"given":"John Paul","family":"Byagamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Opiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Nyafwono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Angwech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey Maxwell","family":"Malinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Echodu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Igwaro","family":"Odongo-Aginya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"8","key":"13757_CR1","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1371\/journal.pntd.0000412","volume":"3","author":"PJ Hotez","year":"2009","unstructured":"Hotez PJ, Kamath A. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis. 2009;3(8):e412.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9936","key":"13757_CR2","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383(9936):2253\u201364.","journal-title":"Lancet"},{"issue":"10258","key":"13757_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"key":"13757_CR4","volume-title":"WHO guideline on control and elimination of human schistosomiasis","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. WHO guideline on control and elimination of human schistosomiasis. Geneva: World Health Organization; 2022."},{"issue":"7","key":"13757_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.pt.2006.05.001","volume":"22","author":"NB Kabatereine","year":"2006","unstructured":"Kabatereine NB, Fleming FM, Nyandindi U, Mwanza JC, Blair L. The control of schistosomiasis and soil-transmitted helminths in East Africa. Trends Parasitol. 2006;22(7):332\u20139.","journal-title":"Trends Parasitol"},{"issue":"8","key":"13757_CR6","doi-asserted-by":"publisher","first-page":"e0011506","DOI":"10.1371\/journal.pntd.0011506","volume":"17","author":"PS Andrus","year":"2023","unstructured":"Andrus PS, Stothard JR, Wade CM. Seasonal patterns of Schistosoma mansoni infection within Biomphalaria snails at the Ugandan shorelines of Lake Albert and Lake Victoria. PLoS Negl Trop Dis. 2023;17(8):e0011506.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"13757_CR7","first-page":"502","volume":"73","author":"NB Kabatereine","year":"1996","unstructured":"Kabatereine NB, Odongo-Aginya EI, Lakwo TL. Schistosoma mansoni along Lake Albert, Kibale District, Western Uganda. East Afr Med J. 1996;73(8):502\u20134.","journal-title":"East Afr Med J"},{"issue":"12","key":"13757_CR8","doi-asserted-by":"publisher","first-page":"e0009375","DOI":"10.1371\/journal.pntd.0009375","volume":"15","author":"MM Nigo","year":"2021","unstructured":"Nigo MM, Odermatt P, Nigo DW, Salieb-Beugelaar GB, Battegay M, Hunziker PR. Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo. PLoS Negl Trop Dis. 2021;15(12):e0009375.","journal-title":"PLoS Negl Trop Dis"},{"key":"13757_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fimmu.2013.00089","volume":"4","author":"E Hams","year":"2013","unstructured":"Hams E, Aviello G, Fallon PG. The Schistosoma granuloma: friend or foe? Front Immunol. 2013;4:89.","journal-title":"Front Immunol"},{"issue":"1","key":"13757_CR10","doi-asserted-by":"publisher","first-page":"e0005524","DOI":"10.1371\/journal.pntd.0005524","volume":"12","author":"AE Ezeamama","year":"2018","unstructured":"Ezeamama AE, Bustinduy AL, Nkwata AK, Martinez L, Pabalan N, Boivin MJ, et al. Cognitive deficits and educational loss in children with schistosome infection. A systematic review and meta-analysis. PLoS Negl Trop Dis. 2018;12(1):e0005524.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"13757_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40249-021-00919-z","volume":"10","author":"D Rinaldo","year":"2021","unstructured":"Rinaldo D, Perez-Saez J, Vounatsou P, Utzinger J, Arcand JL. The economic impact of schistosomiasis. Infect Dis poverty. 2021;10(1):134.","journal-title":"Infect Dis poverty"},{"issue":"2","key":"13757_CR12","doi-asserted-by":"publisher","first-page":"e0298332","DOI":"10.1371\/journal.pone.0298332","volume":"19","author":"G Alemu","year":"2024","unstructured":"Alemu G, Hailu S, Abay SM, Dagne H, Ayalew M, Assemie MA, et al. Efficacy and safety of praziquantel for the treatment of Schistosoma mansoni infection: a systematic review and meta-analysis. PLoS ONE. 2024;19(2):e0298332.","journal-title":"PLoS ONE"},{"key":"13757_CR13","first-page":"i","volume":"912","author":"World Health Organization","year":"2002","unstructured":"World Health Organization. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. World Health Organ Tech Rep Ser. 2002;912:i\u2013vi.","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"5","key":"13757_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jpurol.2007.01.198","volume":"3","author":"MD French","year":"2007","unstructured":"French MD, Rollinson D, Bas\u00e1\u00f1ez MG, Mgeni AF, Khamis IS, Stothard JR. School-based control of urinary schistosomiasis on Zanzibar, Tanzania: monitoring micro-haematuria with reagent strips as a rapid urological assessment. J Pediatr Urol. 2007;3(5):364\u20138.","journal-title":"J Pediatr Urol"},{"issue":"7","key":"13757_CR15","doi-asserted-by":"publisher","first-page":"e1758","DOI":"10.1371\/journal.pntd.0001758","volume":"6","author":"LA Tchuem Tchuent\u00e9","year":"2012","unstructured":"Tchuem Tchuent\u00e9 LA, Ku\u00e9t\u00e9 Fouodo CJ, Kamwa Ngassam RI, Sumo L, Dongmo Noumedem C, Kenfack CM, et al. Evaluation of circulating cathodic antigen (CCA) urine-tests for diagnosis of Schistosoma mansoni infection in Cameroon. PLoS Negl Trop Dis. 2012;6(7):e1758.","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"13757_CR16","doi-asserted-by":"publisher","first-page":"e3286","DOI":"10.1371\/journal.pntd.0003286","volume":"8","author":"J Zwang","year":"2014","unstructured":"Zwang J, Olliaro PL. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis: a meta-analysis of comparative and non-comparative clinical trials. PLoS Negl Trop Dis. 2014;8(11):e3286.","journal-title":"PLoS Negl Trop Dis"},{"key":"13757_CR17","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1038\/s41598-024-84621-8","volume":"15","author":"M Sisay","year":"2025","unstructured":"Sisay M, Hailu T, Damtie D, et al. Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis. Sci Rep. 2025;15:4642.","journal-title":"Sci Rep"},{"issue":"5","key":"13757_CR18","doi-asserted-by":"publisher","first-page":"e0324187","DOI":"10.1371\/journal.pone.0324187","volume":"20","author":"G Alemu","year":"2025","unstructured":"Alemu G, Amor A, Nibret E, Munshea A, Anegagrie M. Correction: Efficacy and safety of praziquantel for the treatment of Schistosoma mansoni infection across different transmission settings in Amhara Regional State, northwest Ethiopia. PLoS ONE. 2025;20(5):e0324187.","journal-title":"PLoS ONE"},{"key":"13757_CR19","doi-asserted-by":"publisher","first-page":"968106","DOI":"10.3389\/fphar.2023.968106","volume":"14","author":"TD Gebreyesus","year":"2023","unstructured":"Gebreyesus TD, Makonnen E, Tadele T, Mekete K, Gashaw H, Gerba H, et al. Efficacy and safety of praziquantel preventive chemotherapy in Schistosoma mansoni\u2013infected school children in southern Ethiopia: a prospective cohort study. Front Pharmacol. 2023;14:968106.","journal-title":"Front Pharmacol"},{"issue":"1","key":"13757_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s41182-023-00562-4","volume":"51","author":"T Tadele","year":"2023","unstructured":"Tadele T, Astatkie A, Tadesse BT, Makonnen E, Aklillu E, Abay SM. Efficacy and safety of praziquantel treatment against Schistosoma mansoni infection among pre-school age children in southern Ethiopia. Trop Med Health. 2023;51(1):72.","journal-title":"Trop Med Health"},{"issue":"11","key":"13757_CR21","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.3390\/biomedicines12112463","volume":"12","author":"L Fok","year":"2024","unstructured":"Fok L, Brett-Major DM, Erko B, Linville J, Dai HD, Negash Y, et al. Efficacy of praziquantel in treating Schistosoma haematobium infection among Ethiopian children. Biomedicines. 2024;12(11):2463.","journal-title":"Biomedicines"},{"key":"13757_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijpddr.2020.10.003","volume":"14","author":"B Levecke","year":"2020","unstructured":"Levecke B, Vlaminck J, Andriamaro L, Ame S, Belizario V, Degarege A, et al. Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs. Int J Parasitol Drugs Drug Resist. 2020;14:183\u20137.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"13757_CR23","doi-asserted-by":"publisher","first-page":"1471451","DOI":"10.3389\/fpara.2024.1471451","volume":"3","author":"G Eastham","year":"2024","unstructured":"Eastham G, Fausnacht DW, Becker MH, Gillen A, Moore WT. Praziquantel resistance in schistosomes: a brief report. Front Parasitol. 2024;3:1471451.","journal-title":"Front Parasitol"},{"issue":"9","key":"13757_CR24","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/cid\/ciw506","volume":"63","author":"T Crellen","year":"2016","unstructured":"Crellen T, Walker M, Lamberton PHL, Kabatereine NB, Tukahebwa EM, Cotton JA, et al. Reduced efficacy of praziquantel against Schistosoma mansoni is associated with multiple rounds of mass drug administration. Clin Infect Dis. 2016;63(9):1151\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"13757_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13071-021-05121-6","volume":"15","author":"SCM Trienekens","year":"2022","unstructured":"Trienekens SCM, Faust CL, Besigye F, Pickering L, Tukahebwa EM, Seeley J, et al. Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity. Parasites Vectors. 2022;15(1):15.","journal-title":"Parasites Vectors"},{"issue":"6","key":"13757_CR26","doi-asserted-by":"publisher","first-page":"e1165","DOI":"10.1371\/journal.pntd.0001165","volume":"5","author":"PL Olliaro","year":"2011","unstructured":"Olliaro PL, Vaillant MT, Belizario VJ, Lwambo NJ, Ouldabdallahi M, Pieri OS, et al. A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40\u00a0mg\/kg vs. 60\u00a0mg\/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil. PLoS Negl Trop Dis. 2011;5(6):e1165.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"13757_CR27","doi-asserted-by":"publisher","first-page":"9530","DOI":"10.1038\/s41467-024-53519-4","volume":"15","author":"F Reitzug","year":"2024","unstructured":"Reitzug F, Kabatereine NB, Byaruhanga AM, Besigye F, Nabatte B, Chami GF. Current water contact and Schistosoma mansoni infection have distinct determinants: a data-driven population-based study in rural Uganda. Nat Commun. 2024;15(1):9530.","journal-title":"Nat Commun"},{"key":"13757_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40249-025-01285-w","volume":"14","author":"PN Mwinzi","year":"2025","unstructured":"Mwinzi PN, Chimbari M, Sylla K, Odiere MR, Midzi N, Ruberanziza E, et al. Priority knowledge gaps for schistosomiasis research and development in the World Health Organization Africa Region. Infect Dis Poverty. 2025;14:19.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"13757_CR29","doi-asserted-by":"publisher","first-page":"e0004329","DOI":"10.1371\/journal.pntd.0004329","volume":"10","author":"RK Assar\u00e9","year":"2016","unstructured":"Assar\u00e9 RK, Tian-Bi YNT, Yao PK, N\u2019Guessan NA, Ouattara M, Yapi A, et al. Sustaining control of Schistosoma mansoni in western C\u00f4te d\u2019Ivoire: results from a SCORE study, one year after initial praziquantel administration. PLoS Negl Trop Dis. 2016;10(1):e0004329.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"13757_CR30","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.4269\/ajtmh.17-0368","volume":"97","author":"N Kittur","year":"2017","unstructured":"Kittur N, Binder S, Campbell CH, King CH, Kinung\u2019hi S, Olsen A, et al. Defining persistent hotspots: areas that fail to decrease meaningfully in prevalence after multiple years of mass drug administration with praziquantel for control of schistosomiasis. Am J Trop Med Hyg. 2017;97(6):1810\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"13757_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40249-022-01003-w","volume":"11","author":"J Xu","year":"2022","unstructured":"Xu J, Li S-Z, Zhou X-N. The WHO new guideline to control and eliminate human schistosomiasis: implications and challenges. Infect Dis Poverty. 2022;11:61.","journal-title":"Infect Dis Poverty"},{"issue":"21","key":"13757_CR32","doi-asserted-by":"publisher","first-page":"11537","DOI":"10.3390\/ijerph182111537","volume":"18","author":"Y Jin","year":"2021","unstructured":"Jin Y, Lee Y-H, Cha S, Choi I-U, Ismail HAHA, Elhag MS, et al. Transmission dynamics of Schistosoma haematobium among school-aged children: a cohort study on prevalence, reinfection and incidence after mass drug administration in the White Nile State of Sudan. Int J Environ Res Public Health. 2021;18(21):11537.","journal-title":"Int J Environ Res Public Health"},{"key":"13757_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.actatropica.2018.06.009","volume":"185","author":"M Adriko","year":"2018","unstructured":"Adriko M, Tinkitina B, Tukahebwa EM, Rugunda G, Rujeni N. The epidemiology of schistosomiasis in Lango region, Uganda: 60 years after Schwetz (1951). Acta Trop. 2018;185:412\u20138.","journal-title":"Acta Trop"},{"key":"13757_CR34","doi-asserted-by":"crossref","unstructured":"Byagamy JP, Opiro R, Nyafwono M, Malinga GM, Echodu R, Odongo-Aginya E. Prevalence, intensity, and risk factors of Schistosoma mansoni and other intestinal parasites: a cross-sectional study in rural agricultural communities of Lango Subregion, Uganda. J Parasitol Res. 2025;2025:8867072.","DOI":"10.1155\/japr\/8867072"},{"key":"13757_CR35","volume-title":"Uganda Neglected Tropical Diseases Master Plan 2023\u20132027","author":"Ministry of Health Uganda","year":"2023","unstructured":"Ministry of Health Uganda. Uganda Neglected Tropical Diseases Master Plan 2023\u20132027. Kampala: Ministry of Health; 2023."},{"issue":"1","key":"13757_CR36","first-page":"33","volume":"7","author":"EI Odongo-Aginya","year":"2007","unstructured":"Odongo-Aginya EI, Kabatereine N, Ludwig S, Wabinga H, Fenwick A, Montresor A. Substitution of malachite green with nigrosin-eosin yellow stain in the Kato-Katz method: microscopical appearance of the helminth eggs. Afr Health Sci. 2007;7(1):33\u20136.","journal-title":"Afr Health Sci"},{"key":"13757_CR37","volume-title":"Lango Sub-Region Census 2024 Profile Report [Internet]","author":"Uganda Bureau of Statistics (UBOS)","year":"2025","unstructured":"Uganda Bureau of Statistics (UBOS). Lango Sub-Region Census 2024 Profile Report [Internet]. Kampala: Uganda Bureau of Statistics; 2025. Jun 2 [cited 2025 Nov 3]."},{"key":"13757_CR38","volume-title":"Uganda Household and Income Survey 2021\/22 \u2013 Agriculture Module [Internet]","author":"Uganda Bureau of Statistics (UBOS)","year":"2025","unstructured":"Uganda Bureau of Statistics (UBOS). Uganda Household and Income Survey 2021\/22 \u2013 Agriculture Module [Internet]. Kampala: Uganda Bureau of Statistics; 2025. [cited 2025 Nov 3]."},{"key":"13757_CR39","volume-title":"[Internet]March\u2013May (MAM) 2025 seasonal climate outlook over Uganda","author":"Ministry of Water and Environment (Uganda)","year":"2025","unstructured":"Ministry of Water and Environment (Uganda). Uganda National Meteorological Authority. March\u2013May (MAM) 2025 seasonal climate outlook over Uganda [Internet]. Kampala: MWE\/UNMA; 2025. Mar 21 [cited 2025 Nov 3]."},{"key":"13757_CR40","volume-title":"Biostatistics: A Foundation for Analysis in the Health Sciences","author":"WW Daniel","year":"1999","unstructured":"Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. 7th ed. New York: Wiley; 1999.","edition":"7"},{"issue":"1","key":"13757_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40249-017-0293-3","volume":"4","author":"M Kabuyaya","year":"2017","unstructured":"Kabuyaya M, Chimbari MJ, Manyangadze T, Mukaratirwa S. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa. Infect Dis Poverty. 2017;4(1):83.","journal-title":"Infect Dis Poverty"},{"issue":"7","key":"13757_CR42","first-page":"311","volume":"87","author":"EI Odongo-Aginya","year":"2010","unstructured":"Odongo-Aginya EI, Doehring E. Bilharzia induced pathologies and techniques of detection in Uganda: a review. East Afr Med J. 2010;87(7):311\u20136.","journal-title":"East Afr Med J"},{"key":"13757_CR43","volume-title":"Uganda Clinical Guidelines 2023: National Guidelines for Management of Common Conditions","author":"Uganda Ministry of Health","year":"2023","unstructured":"Uganda Ministry of Health. Uganda Clinical Guidelines 2023: National Guidelines for Management of Common Conditions. Kampala: Ministry of Health; 2023."},{"key":"13757_CR44","volume-title":"IBM SPSS Statistics for Windows, Version 25.0","author":"IBM Corp","year":"2017","unstructured":"IBM Corp. IBM SPSS Statistics for Windows, Version 25.0. Armonk (NY): IBM Corp; 2017."},{"key":"13757_CR45","unstructured":"Alemu A, Gemeda M, Tiruneh M, Tsegaye S, Taye B, Terefe G, et al. Prevalence and reinfection rates of Schistosoma mansoni and praziquantel efficacy against the parasite among primary school children in Sanja Town, Northwest Ethiopia. J Trop Med. 2023;2023:9876543."},{"key":"13757_CR46","doi-asserted-by":"publisher","DOI":"10.1201\/b12670","volume-title":"Confidence intervals for proportions and related measures of effect size","author":"RG Newcombe","year":"2012","unstructured":"Newcombe RG. Confidence intervals for proportions and related measures of effect size. Boca Raton: CRC; 2012."},{"issue":"12","key":"13757_CR47","first-page":"e080208","volume":"13","author":"O Mousa","year":"2023","unstructured":"Mousa O, Al-Tawfiq JA, Alshukairi J, Alahmadi R, Aljohani S, Alsulaiman M, et al. Incidence and reinfection of mild and severe cases of SARS-CoV-2 infection in children in Riyadh, Saudi Arabia: a prospective cohort study. BMJ Open. 2023;13(12):e080208.","journal-title":"BMJ Open"},{"issue":"21","key":"13757_CR48","doi-asserted-by":"publisher","first-page":"11537","DOI":"10.3390\/ijerph182111537","volume":"18","author":"Y Jin","year":"2021","unstructured":"Jin Y, Lee YH, Cha S, Choi IU, Ismail HAHA, Elhag MS, et al. Transmission dynamics of Schistosoma haematobium among school-aged children: a cohort study on prevalence, reinfection and incidence after mass drug administration in the White Nile State of Sudan. Int J Environ Res Public Health. 2021;18(21):11537.","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"13757_CR49","doi-asserted-by":"publisher","first-page":"e0013827","DOI":"10.1371\/journal.pntd.0013827","volume":"19","author":"JP Byagamy","year":"2025","unstructured":"Byagamy JP, Opiro R, Angwech H, Nyafwono M, Malinga GM, Echodu R, et al. Prevalence, intensity, and risk factors of schistosomiasis and intestinal parasitic infections among primary school children in northern Uganda: Implications for public health interventions. PLoS Negl Trop Dis. 2025;19(12):e0013827.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"13757_CR50","first-page":"95","volume":"90","author":"A Katungi","year":"2013","unstructured":"Katungi A, Redeker S, Kiiza P, Ocaka J, Van Goor A, Polderman AM, et al. Reassessment of helminth infections in Gulu municipality northern Uganda after the twenty years of insurgency: using three diagnostic methods to compare their sensitivity. East Afr Med J. 2013;90(3):95\u2013103.","journal-title":"East Afr Med J"},{"key":"13757_CR51","volume-title":"Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021\u20132030","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021\u20132030. Geneva: World Health Organization; 2020."},{"issue":"8","key":"13757_CR52","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1473-3099(15)00066-3","volume":"15","author":"YS Lai","year":"2015","unstructured":"Lai YS, Biedermann P, Ekpo UF, Garba A, Mathieu E, Midzi N, et al. Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis. Lancet Infect Dis. 2015;15(8):927\u201340.","journal-title":"Lancet Infect Dis"},{"key":"13757_CR53","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.actatropica.2016.03.028","volume":"159","author":"T Manyangadze","year":"2016","unstructured":"Manyangadze T, Chimbari MJ, Gebreslasie M, Mukaratirwa S. Risk factors and micro-geographical heterogeneity of Schistosoma haematobium in Ndumo area, uMkhanyakude District, KwaZulu-Natal, South Africa. Acta Trop. 2016;159:176\u201384.","journal-title":"Acta Trop"},{"key":"13757_CR54","volume-title":"Schistosomiasis","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Schistosomiasis. Geneva: World Health Organization; 2023. [cited 2025 Nov 3]."},{"key":"13757_CR55","unstructured":"World Health Organization. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization; 2006."},{"issue":"10","key":"13757_CR56","doi-asserted-by":"publisher","first-page":"e0005953","DOI":"10.1371\/journal.pntd.0005953","volume":"11","author":"O B\u00e4renbold","year":"2017","unstructured":"B\u00e4renbold O, Raso G, Coulibaly JT, N\u2019Goran EK, Utzinger J, Vounatsou P. Estimating sensitivity of the Kato\u2013Katz technique for the diagnosis of Schistosoma mansoni and hookworm in relation to infection intensity. PLoS Negl Trop Dis. 2017;11(10):e0005953.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"13757_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4314\/ajid.v4i2.55147","volume":"4","author":"EI Odongo-Aginya","year":"2010","unstructured":"Odongo-Aginya EI, Lakwo TL, Doehring ME. Evaluation of schistosoma mansoni morbidity one year after praziquantel treatment in Rhino Camp and Obongi in West Nile, Uganda. Afr J Infect Dis. 2010;4(2):43\u201350.","journal-title":"Afr J Infect Dis"},{"issue":"2","key":"13757_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4314\/ajid.v5i2.66511","volume":"5","author":"EI Odongo-Aginya","year":"2011","unstructured":"Odongo-Aginya EI, Kironde FK, Lyazi MI, Sempewo H, Correa-Oliveira R. Evidence of long term benefit of morbidity reduction due to praziquantel treatment against schistosoma mansoni in Kigungu fishing village in Entebbe, Uganda. Afr J Infect Dis. 2011;5(2):33\u20139.","journal-title":"Afr J Infect Dis"},{"issue":"6","key":"13757_CR59","doi-asserted-by":"publisher","first-page":"927","DOI":"10.4269\/ajtmh.1999.60.927","volume":"60","author":"K Frenzel","year":"1999","unstructured":"Frenzel K, Grigull L, Odongo-Aginya E, Ndugwa CM, Loroni-Lakwo T, Schweigmann U, et al. Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda. Am J Trop Med Hyg. 1999;60(6):927\u201331.","journal-title":"Am J Trop Med Hyg"},{"key":"13757_CR60","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s13071-015-0980-5","volume":"8","author":"B Senghor","year":"2015","unstructured":"Senghor B, Diaw OT, Doucoure S, et al. Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese schoolchildren where there is a single well-defined transmission period. Parasites Vectors. 2015;8:362.","journal-title":"Parasites Vectors"},{"issue":"3","key":"13757_CR61","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4269\/ajtmh.15-0725","volume":"94","author":"N Kittur","year":"2016","unstructured":"Kittur N, Castleman JD, Campbell CH Jr, King CH, Colley DG. Comparison of Schistosoma mansoni prevalence and intensity of infection, as determined by the circulating cathodic antigen urine assay or by the Kato\u2013Katz fecal assay: a systematic review. Am J Trop Med Hyg. 2016;94(3):605\u201310.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"13757_CR62","doi-asserted-by":"publisher","first-page":"e0006274","DOI":"10.1371\/journal.pntd.0006274","volume":"12","author":"CG Lindholz","year":"2018","unstructured":"Lindholz CG, Favero V, Verissimo CM, Candido RRF, de Souza RP, dos Santos RR, Morassutti AL, Bittencourt HR, Jones MK, St Pierre TG, Graeff-Teixeira C. Study of diagnostic accuracy of Helmintex, Kato-Katz, and POC-CCA methods for diagnosing intestinal schistosomiasis in Candeal, a low intensity transmission area in northeastern Brazil. PLoS Negl Trop Dis. 2018;12(3):e0006274.","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"13757_CR63","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1590\/S0074-02762011000700010","volume":"106","author":"LMV Siqueira","year":"2011","unstructured":"Siqueira LMV, Coelho PMZ, Oliveira \u00c1A, Massara CL, Carneiro NFF, Lima ACL, Enk MJ. Evaluation of two coproscopic techniques for the diagnosis of schistosomiasis in a low-transmission area in the state of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz. 2011;106(7):844\u201350.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"13757_CR64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1365-3156.1999.00356.x","volume":"4","author":"M Ramsan","year":"1999","unstructured":"Ramsan M, Montresor A, Foum A, Ameri H, Di Matteo L, Albonico M, et al. Independent evaluation of the Nigrosin-Eosin modification of the Kato-Katz technique. Trop Med Int Health. 1999;4(1):46\u20139.","journal-title":"Trop Med Int Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13757-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13757-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13757-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:03:26Z","timestamp":1786626206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13757-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13757"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13757-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8486809\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was granted by the Gulu University Research and Ethics Committee (Reference: GUREC-2022-323) and the Uganda National Council for Science and Technology (Reference: UNCST-HS2571ES). Permission to conduct the study was also obtained from district education officers and headteachers of the participating schools. Written informed consent was secured from all parents or legal guardians. Additionally, written assent was obtained from all children aged 8 years and above. All procedures performed in this study were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki declaration and its later amendments. All methods were carried out in accordance with the relevant guidelines and regulations. To ensure confidentiality, all participant data were anonymized using identification codes. All children diagnosed with\n                      S. mansoni\n                      infection during the study were treated with praziquantel at a dose of 40\u00a0mg\/kg, free of charge, in accordance with national treatment guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1475"}}